Appendix B
WORKSHOP SPEAKERS,* MODERATORS,† AND INVITED DISCUSSANTS‡

Ken Anderson, M.D., Dana-Farber Cancer Institute*

Don Berry, Ph.D., MD Anderson Cancer Center*

David Carbone, M.D., Ph.D., Vanderbilt University*

David Chang, M.D., Ph.D., Amgen, Inc.‡

Rick Chappell, Ph.D., University of Wisconsin‡

Jerry Collins, Ph.D., National Cancer Institute‡

Robert Comis, M.D., Coalition of National Cancer Cooperative Groups*

Janet Dancey, M.D., National Cancer Institute*

James Doroshow, M.D., National Cancer Institute*†

Giulio Draetta, M.D., Ph.D., Merck Research Laboratories†‡

Susan Ellenberg, Ph.D., University of Pennsylvania*

Jeff Evelhoch, Ph.D., Amgen, Inc.*‡

Gwen Fyfe, M.D., Genentech, Inc.*

John Gore, Ph.D., Vanderbilt University*

Joe Gray, Ph.D., University of California–San Francisco Comprehensive Cancer Center*

Steven Gutman, M.D., Food and Drug Administration*

Sam Hanash, M.D., Ph.D., Fred Hutchinson Cancer Research Center‡



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 123
Appendix B WORKSHOP SPEAKERS,* MODERATORS,† AND INVITED DISCUSSANTS‡ Ken Anderson, M.D., Dana-Farber Cancer Institute* Don Berry, Ph.D., MD Anderson Cancer Center* David Carbone, M.D., Ph.D., Vanderbilt University* David Chang, M.D., Ph.D., Amgen, Inc.‡ Rick Chappell, Ph.D., University of Wisconsin‡ Jerry Collins, Ph.D., National Cancer Institute‡ Robert Comis, M.D., Coalition of National Cancer Cooperative Groups* Janet Dancey, M.D., National Cancer Institute* James Doroshow, M.D., National Cancer Institute*† Giulio Draetta, M.D., Ph.D., Merck Research Laboratories†‡ Susan Ellenberg, Ph.D., University of Pennsylvania* Jeff Evelhoch, Ph.D., Amgen, Inc.*‡ Gwen Fyfe, M.D., Genentech, Inc.* John Gore, Ph.D., Vanderbilt University* Joe Gray, Ph.D., University of California–San Francisco Comprehensive Cancer Center* Steven Gutman, M.D., Food and Drug Administration* Sam Hanash, M.D., Ph.D., Fred Hutchinson Cancer Research Center‡ 

OCR for page 123
 IMPROVING THE QUALITY OF CANCER CLINICAL TRIALS James Heath, Ph.D., California Institute of Technology* Roy Herbst, M.D., Ph.D., MD Anderson Cancer Center*† Hedvig Hricak, M.D., Ph.D., Memorial Sloan-Kettering Cancer Center*† David Jacobson-Kram, Ph.D., Food and Drug Administration* Susan Jerian, M.D., OncoRD, Inc.* Mark Kris, M.D., Memorial Sloan-Kettering Cancer Center* Raju Kucherlapati, Ph.D., Harvard Partners Center for Genetics and Genomics* Steven Larson, M.D., Memorial Sloan-Kettering Cancer Center* Jack Lee, Ph.D., MD Anderson Cancer Center* Pierre Massion, M.D., Vanderbilt University*† Tim McCarthy, Ph.D., Pfizer, Inc.*‡ John Mendelsohn, M.D., MD Anderson Cancer Center*† George Mills, M.D., Parexel International Corporation*† Hal Moses, M.D., Vanderbilt-Ingram Cancer Center* William Pao, M.D., Ph.D., Memorial Sloan-Kettering Cancer Center* David Piwnica-Worms, M.D., Ph.D., Washington University School of Medicine*† Richard Schilsky, M.D., University of Chicago‡ Kevin Schulman, M.D., Duke University Medical School* Lawrence Schwartz, M.D., Memorial Sloan-Kettering Cancer Center* Steven Shak, M.D., Genomic Health, Inc.* Joseph Sparano, M.D., Albert Einstein Comprehensive Cancer Center* Ellen Stovall, National Coalition for Cancer Survivorship* Daniel Sullivan, M.D., Duke University* Daniel Von Hoff, M.D., Translational Genomics Research Institute* John Wagner, M.D., Ph.D., Merck Research Laboratories† Janet Woodcock, M.D., Food and Drug Administration *†